Amniotic Tissues for the Treatment of Chronic Plantar Fasciosis and Achilles Tendinosis

Abstract EN

Introduction.

Allogeneic amniotic tissue and fluid may be used to treat chronic plantar fasciosis and Achilles tendinosis.

This innovative approach involves delivering a unique allograft of live human cells in a nonimmunogenic structural tissue matrix to treat chronic tendon injury.

These tissues convey very positive regenerative attributes; procurement is performed with maternal consent during elective caesarian birth.

Materials and Methods.

In the present investigation all patients were unresponsive to multiple standard therapies for a minimum of 6 months and were treated with one implantation of PalinGen SportFLOW around the plantar fascia and/or around the Achilles paratenon.

The patients were given a standard protocol for postimplant active rehabilitation.

Results.

The analogue pretreatment pain score (VAS) of 8.

By the fourth week after treatment, all patients had significantly reduced self-reported pain.

Twelve weeks following the procedure the average pain level had reduced to only 2.

No adverse reactions were reported in any of the patients.

Conclusion.

All patients in this study experienced heel or Achilles pain, unresponsive to standard therapy protocols.

After treatment all patients noted significant pain reduction, indicating that granulized amniotic membrane and amniotic fluid can be successfully used to treat both chronic plantar fasciosis and Achilles tendinosis.